Abstract
This case report indicates the usefulness of voriconazole for the treatment of central nervous system (CNS) aspergillosis, also in paediatrics. However, it also confirms the need for therapeutic drug monitoring (TDM), especially in younger children that may require very high dosages in order to achieve plasma and cerebrospinal fluid (CSF) therapeutic concentrations.
Original language | English |
---|---|
Pages (from-to) | 1-3 |
Number of pages | 3 |
Journal | Journal of Chemotherapy |
DOIs | |
Publication status | Accepted/In press - Apr 7 2016 |
Keywords
- Cerebral aspergillosis
- Cerebrospinal fluid concentrations
- Children
- Leukaemia
- Voriconazole
ASJC Scopus subject areas
- Pharmacology (medical)
- Infectious Diseases
- Oncology
- Pharmacology